Azithromycin induces liver injury in mice by targeting the AMPK/Nrf2 pathway

Qixiang Xu,Cuifeng Zhang,Jingwen Lu,Haiyi Qian,Xiaodong Wang,Wenjun Guo,Huixian Cheng
DOI: https://doi.org/10.1080/08923973.2024.2415115
IF: 3.712
2024-10-17
Immunopharmacology and Immunotoxicology
Abstract:Background Azithromycin is an antibacterial and anti-inflammatory drug widely used for the treatment of various diseases, including those caused by atypical pathogens, bacterial or viral infections, chronic sinusitis, and bronchial asthma, particularly in pediatric patients. However, concerns have emerged regarding its hepatotoxicity and its precise mechanism of action remains unclear.
pharmacology & pharmacy,immunology,toxicology
What problem does this paper attempt to address?